SMOFlipid 20%

SMOFlipid 20% Overdosage

Manufacturer:

Fresenius Kabi

Distributor:

Zuellig Pharma
Full Prescribing Info
Overdosage
Overdose leading to fat overload syndrome may occur as a result of a too rapid infusion rate, or chronically at recommended rates of infusion in association with a change in the patients clinical conditions e.g. renal function impairment or infection.
Overdosage may lead to side effects (see Adverse Reactions). In these cases the lipid infusion should be stopped or, if necessary, continued at a reduced dosage.
Sign up for Free to continue reading
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in